| Dr Binoy R Jani, MD | |
|
927 Maple Grove Dr Ste 209, Fredericksburg, VA 22407-6936 | |
| (540) 208-5827 | |
| Not Available |
| Full Name | Dr Binoy R Jani |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 28 Years |
| Location | 927 Maple Grove Dr Ste 209, Fredericksburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548222557 | NPI | - | NPPES |
| 010218021 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 010123124 (Virginia) | Secondary |
| 207W00000X | Ophthalmology | 0101231244 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vista Eye Specialists Pc | 2769536598 | 3 |
| David M Harman Md Llc | 6305828062 | 45 |
News Archive
Twenty years after the House of Commons resolved to end child poverty in Canada one in every nine children in Ontario still lives in poverty and the recession will deepen the problem, says the 2009 Ontario Report Card on Child Poverty by Ontario Campaign 2000.
Mathematicians at the University of Liverpool have found that it is possible to gain full control of sound waves which could lead to improved medical scans, for technology such as ultra sound machines
Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.
› Verified 8 days ago
| Entity Name | Mcv Associated Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710959457 PECOS PAC ID: 4385542117 Enrollment ID: O20031230000559 |
News Archive
Twenty years after the House of Commons resolved to end child poverty in Canada one in every nine children in Ontario still lives in poverty and the recession will deepen the problem, says the 2009 Ontario Report Card on Child Poverty by Ontario Campaign 2000.
Mathematicians at the University of Liverpool have found that it is possible to gain full control of sound waves which could lead to improved medical scans, for technology such as ultra sound machines
Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.
› Verified 8 days ago
| Entity Name | David M Harman Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306950431 PECOS PAC ID: 6305828062 Enrollment ID: O20040605000053 |
News Archive
Twenty years after the House of Commons resolved to end child poverty in Canada one in every nine children in Ontario still lives in poverty and the recession will deepen the problem, says the 2009 Ontario Report Card on Child Poverty by Ontario Campaign 2000.
Mathematicians at the University of Liverpool have found that it is possible to gain full control of sound waves which could lead to improved medical scans, for technology such as ultra sound machines
Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.
› Verified 8 days ago
| Entity Name | Vista Eye Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649408253 PECOS PAC ID: 2769536598 Enrollment ID: O20090813000401 |
News Archive
Twenty years after the House of Commons resolved to end child poverty in Canada one in every nine children in Ontario still lives in poverty and the recession will deepen the problem, says the 2009 Ontario Report Card on Child Poverty by Ontario Campaign 2000.
Mathematicians at the University of Liverpool have found that it is possible to gain full control of sound waves which could lead to improved medical scans, for technology such as ultra sound machines
Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Binoy R Jani, MD 2010 Bremo Rd Ste 128a, Richmond, VA 23226-2444 Ph: (877) 969-0392 | Dr Binoy R Jani, MD 927 Maple Grove Dr Ste 209, Fredericksburg, VA 22407-6936 Ph: (540) 208-5827 |
News Archive
Twenty years after the House of Commons resolved to end child poverty in Canada one in every nine children in Ontario still lives in poverty and the recession will deepen the problem, says the 2009 Ontario Report Card on Child Poverty by Ontario Campaign 2000.
Mathematicians at the University of Liverpool have found that it is possible to gain full control of sound waves which could lead to improved medical scans, for technology such as ultra sound machines
Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.
› Verified 8 days ago
Christopher Shen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 12 Chatham Heights Rd, Suite 100, Fredericksburg, VA 22405 Phone: 540-371-2777 Fax: 540-371-0922 | |
Diemngoc T. Dang, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4710 Spotsylvania Pkwy, Suite 104, Fredericksburg, VA 22407 Phone: 540-741-2733 | |
Dr. Thomas Falkenberg, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 12 Chatham Heights Rd, Suite 100, Fredericksburg, VA 22405 Phone: 540-371-2777 Fax: 540-371-0922 | |
Dr. Thomas Mark Johnson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Executive Center Pkwy, Suite 102, Fredericksburg, VA 22401 Phone: 540-654-5333 Fax: 540-654-5334 | |
Steven J Hudson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 12 Chatham Heights Rd, Suite 100, Fredericksburg, VA 22405 Phone: 540-371-2777 Fax: 540-371-0922 | |
Matthew Tadrus, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Cambridge St, Fredericksburg, VA 22405 Phone: 540-371-2020 Fax: 540-373-0141 |